Type to search

InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers | Pharmtech Focus
Curebase Secures $40 Million in Series B Funding | Pharmtech Focus
AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II | Pharmtech Focus